抗抑郁药继续使用与序贯心理干预预防抑郁复发的个体参与者数据荟萃分析
该个体参与者数据荟萃分析纳入4项随机临床试验共714例抑郁缓解期患者,比较在抗抑郁药减量期间和/或之后给予心理干预与单用抗抑郁药对15个月内复发风险的影响。结果显示两组复发时间无显著差异(HR 0.86,95%CI 0.60-1.23),序贯心理干预可能作为长期用抗抑郁药的替代复发预防策略。
要点
- 减量期和/或之后心理干预与单用抗抑郁药的复发时间无显著差异。
- 起病年龄小、缓解期短、基线残留症状重与总体复发风险更高相关。
- 纳入的调节因素均与复发风险无显著关联。
核心结论
- 无论研究纳入的临床因素如何,在抗抑郁药减量期间和/或之后序贯提供心理干预可能是替代长期使用抗抑郁药的有效复发预防策略。
研究设计与样本
- 个体参与者数据荟萃分析,纳入4项比较减量期和/或之后心理干预与抗抑郁药单药的随机临床试验,共714例抑郁完全或部分缓解患者。
主要发现
- 心理干预与单用抗抑郁药相比,抑郁复发时间无显著差异(HR 0.86;95%CI 0.60-1.23)。
- 起病年龄较小(HR 0.98;95%CI 0.97-0.99)与总体复发风险更高相关。
- 缓解期较短(HR 0.99;95%CI 0.98-1.00)与总体复发风险更高相关。
- 基线残留抑郁症状水平较高(HR 1.07;95%CI 1.04-1.10)与总体复发风险更高相关。
- 纳入的调节因素均与复发风险无显著关联。
临床怎么用
- 结果可用于临床实践中的共享决策,支持在部分患者中考虑以序贯心理干预替代长期抗抑郁药治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression frequently recurs. To prevent relapse, antidepressant medication is often taken in the long term. Sequentially delivering a psychological intervention while undergoing tapering of antidepressant medication might be an alternative to long-term antidepressant use. However, evidence is lacking on which patients may benefit from tapering antidepressant medication while receiving a psychological intervention and which should continue the antidepressant therapy. A meta-analysis of individual patient data with more power and precision than individual randomized clinical trials or a standard meta-analysis is warranted. OBJECTIVES: To compare the associations between use of a psychological intervention during and/or after antidepressant tapering vs antidepressant use alone on the risk of relapse of depression and estimate associations of individual clinical factors with relapse. DATA SOURCES: PubMed, the Cochrane Library, Embase, and PsycInfo were last searched on January 23, 2021. Requests for individual participant data from included randomized clinical trials (RCTs) were sent. STUDY SELECTION: Randomized clinical trials that compared use of a psychological intervention while tapering antidepressant medication with antidepressant monotherapy were included. Patients had to be in full or partial remission from depression. Two independent assessors conducted screening and study selection. DATA EXTRACTION AND SYNTHESIS: Of 15 792 screened studies, 236 full-text articles were retrieved, and 4 RCTs that provided individual participant data were included. MAIN OUTCOMES AND MEASURES: Time to relapse and relapse status over 15 months measured via a blinded assessor using a diagnostic clinical interview. RESULTS: Individual data from 714 participants (mean [SD] age, 49.2 [11.5] years; 522 [73.1%] female) from 4 RCTs that compared preventive cognitive therapy or mindfulness-based cognitive therapy during and/or after antidepressant tapering vs antidepressant monotherapy were available. Two-stage random-effects meta-analysis found no significant difference in time to depressive relapse between use of a psychological intervention during tapering of antidepressant medication vs antidepressant therapy alone (hazard ratio [HR], 0.86; 95% CI, 0.60-1.23). Younger age at onset (HR, 0.98; 95% CI, 0.97-0.99), shorter duration of remission (HR, 0.99; 95% CI, 0.98-1.00), and higher levels of residual depressive symptoms at baseline (HR, 1.07; 95% CI, 1.04-1.10) were associated with a higher overall risk of relapse. None of the included moderators were associated with risk of relapse. CONCLUSIONS AND RELEVANCE: The findings of this individual participant data meta-analysis suggest that regardless of the clinical factors included in these studies, the sequential delivery of a psychological intervention during and/or after tapering may be an effective relapse prevention strategy instead of long-term use of antidepressants. These results could be used to inform shared decision-making in clinical practice.
引用
- Breedvelt JJF, Warren FC, Segal Z, et al. Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression: An Individual Participant Data Meta-analysis. JAMA Psychiatry. 2021. PMID: 34009273. doi:10.1001/jamapsychiatry.2021.0823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。